Why Emerging Nicotine Products Are Creating New Questions for Insurers The nicotine marketplace has changed dramatically over the past decade. Traditionally, insurance underwriting relied on a relatively simple distinction: applicants
A New Direction in European Nicotine Policy Over the past decade, Europe has been at the centre of some of the world’s most significant debates on tobacco harm reduction. Products
New Research Offers Insights into Consumer Interest and Smoking Status As nicotine pouches continue to gain attention from regulators, researchers, and public health stakeholders, an important question remains: who is
Examining the Scientific Case for Tobacco Harm Reduction As nicotine pouches become an increasingly prominent feature of nicotine policy discussions worldwide, debate often moves faster than the science itself. Regulators,
As nicotine products continue to evolve, regulators and researchers face a recurring challenge: how can the performance of new products be evaluated efficiently, accurately, and consistently without relying exclusively on
As governments consider how to regulate nicotine pouches, one model is becoming increasingly important: treating oral nicotine products not as general consumer goods, but as medicines, natural health products, poisons,
While the European Union does not currently have a dedicated framework for modern nicotine products, several jurisdictions have already developed regulatory approaches that provide useful reference points for policymakers. These
Discussions about nicotine regulation often become polarized. Some policymakers argue that all nicotine products should be treated similarly because they contain an addictive substance. Others argue that regulation should reflect
The global nicotine landscape continues to evolve at a rapid pace. Over the past decade, regulators have focused primarily on traditional tobacco products, vaping devices, heated tobacco products, nicotine pouches,
The decision by France to prohibit nicotine pouches has triggered renewed debate across Europe about the future of nicotine regulation, the role of harm reduction, and the principles that should
The United Kingdom has formally begun the next phase of its tobacco and nicotine regulatory transition. Following Royal Assent of the Tobacco and Vapes Act on 29 April 2026, the
Flavor regulation has become one of the most contested areas in modern nicotine policy. Across the United States, Europe, and global markets at varying stages of regulatory maturity, governments continue